Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult ParticipantsBlood-Borne Infections, Disease Attributes, Genital Diseases, HIV infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted diseaseActive, not recruitingPhase 12025-10-14NCT05217641

3 results · Page 1 of 1

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alabama CRS [31788]BirminghamUnited States1
Bidmc Vcrs [32077]BostonUnited States1
Brigham and Women's Hospital Vaccine CRS [30007]BostonUnited States1
Columbia P&S CRS [30329]New YorkUnited States1
New York Blood Center CRS [31801]New YorkUnited States1
Penn Prevention CRS [30310]PhiladelphiaUnited States1
Seattle Vaccine and Prevention CRS [30331]SeattleUnited States1
UCLA Vine Street Clinic CRS [31607]Los AngelesUnited States1
University of Pittsburgh CRS [1001]PittsburghUnited States1
University of Rochester Vaccines to Prevent HIV Infection CRS [31467]RochesterUnited States1